×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ITOS – iteos therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ITOS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/25
04:35 pm
itos
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025
Low
Report
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025
3/6
06:31 pm
itos
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its price target lowered by analysts at Wells Fargo & Company from $19.00 to $17.00. They now have an "overweight" rating on the stock.
Low
Report
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its price target lowered by analysts at Wells Fargo & Company from $19.00 to $17.00. They now have an "overweight" rating on the stock.
3/6
11:35 am
itos
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its price target lowered by analysts at JPMorgan Chase & Co. from $22.00 to $15.00. They now have an "overweight" rating on the stock.
Low
Report
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its price target lowered by analysts at JPMorgan Chase & Co. from $22.00 to $15.00. They now have an "overweight" rating on the stock.
3/6
08:12 am
itos
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $46.00 price target on the stock.
Low
Report
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $46.00 price target on the stock.
3/5
06:09 pm
itos
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
Low
Report
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
3/5
07:00 am
itos
iTeos Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Medium
Report
iTeos Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
1/16
07:44 am
itos
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Low
Report
iTeos Therapeutics, Inc. (NASDAQ: ITOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
1/13
07:07 am
itos
Egle Therapeutics Strengthens its Executive Leadership Team With the Appointment of Christophe Quéva, Ph.D., as Chief Executive Officer [Yahoo! Finance]
Low
Report
Egle Therapeutics Strengthens its Executive Leadership Team With the Appointment of Christophe Quéva, Ph.D., as Chief Executive Officer [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/11
08:00 pm
itos
Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: McGrath Yvonne
Medium
Report
Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: McGrath Yvonne
3/11
08:00 pm
itos
Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: Gall Matthew
Medium
Report
Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: Gall Matthew
3/11
08:00 pm
itos
Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: Call Matthew
Medium
Report
Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: Call Matthew
3/11
08:00 pm
itos
Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: Detheux Michel
Medium
Report
Form 4 iTeos Therapeutics, Inc. For: Mar 07 Filed by: Detheux Michel
3/5
07:14 am
itos
Form S-8 iTeos Therapeutics, Inc.
Medium
Report
Form S-8 iTeos Therapeutics, Inc.
3/5
07:07 am
itos
Form 10-K iTeos Therapeutics, Inc. For: Dec 31
Medium
Report
Form 10-K iTeos Therapeutics, Inc. For: Dec 31
2/14
04:00 pm
itos
Form SCHEDULE 13G/A iTeos Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
Low
Report
Form SCHEDULE 13G/A iTeos Therapeutics, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
1/13
07:24 am
itos
Form 8-K iTeos Therapeutics, Inc. For: Jan 13
Low
Report
Form 8-K iTeos Therapeutics, Inc. For: Jan 13
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: